Clinical characteristics | Low GRACE group (N = 88) | Intermediate to high GRACE group (N = 64) | P-value |
---|---|---|---|
Age (years), mean ± SD | 55.3 ± 8.5 | 67.7 ± 3.2 | < 0.001 |
Gender, (%) | 0.696 | ||
 Male | 55(62.5) | 38(59.4) | |
 Female | 33(37.5) | 26 (40.6) | |
Time from symptoms onset to fibrinolysis, median (hours) (IQR:25th,75th percentile) | 2.7 (IQR: 2,3.8) | 2.8 (IQR: 2,4.5) | 0.347 |
Time from fibrinolysis to CAG or PCI median (days) (IQR:25th,75th percentile) | 8.5 (IQR:4.6,10.9) | 7.9 (IQR: 3.2,12.0) | 0.482 |
GRACE score, mean ± SD | 100.2 ± 15.7 | 142.2 ± 13.4 | < 0.001 |
LVEF (%) | 54.9 ± 10.6 | 52.5 ± 13.6 | 0.239 |
Preexisting medical conditions, n (%) | |||
 Diabetes | 18 (20.4) | 10.6 (15.6) | 0.448 |
 Hypertension | 39 (44.3) | 27 (42.2) | 0.794 |
 Dyslipidemia | 30 (34.1) | 16 (25.0) | 0.228 |
 Smoking | 50 (56.8) | 34 (53.1) | 0.651 |
 Chronic kidney disease | 3 (3.4) | 3 (4.7) | 0.681 |